Everand Logo

Welcome to Everand!

  • STAT

    Columbia’s dismissal of prominent neuroscientist prompts demand for answers

    Columbia University students and postdoctoral fellows are urging administrators to specify why they closed a prominent neuroscientist's lab and ended his administrative positions.
    by Sharon Begley and Andrew Joseph Mar 12, 2018 3 minutes
    Neuroscientist Thomas Jessell

    Dozens of current and former students and postdoctoral fellows at Columbia University are urging administrators to specify why the school announced last week that it would close the lab of prominent neuroscientist Thomas Jessell and end his administrative positions.

    Columbia has declined to offer any explanation for Jessell’s removal beyond a terse statement that said an investigation had “revealed serious violations of University policies and values governing the behavior of faculty members in an academic environment.” That statement, current and former students say in an , has

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About Plans For Generic Wegovy, Cough Syrup Warnings, And More
    Biocon is developing a generic version of Novo Nordisk's Wegovy and is prepared to conduct a clinical trial next year if needed.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About Cigna Biosimilar Plans, A Vertex Deal In South Africa, And More
    Cigna plans to make copies of AbbVie's Humira arthritis drug available with no out-of-pocket payment to eligible patients in the U.S.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About MorphoSys Drug Risks, An AstraZeneca Admission, And More
    MorphoSys is dealing with a safety issue with pelabresib, the experimental treatment for myelofibrosis and centerpiece of its proposed $3 billion acquisition by Novartis.

    Related